Octagon Therapeutics is a drug discovery platform using systems biology and engineered nutrient inputs to identify novel metabolic drug targets for autoimmune disease, oncology, and bacterial infection. The technology highlights metabolic vulnerabilities in rapidly proliferating cell populations using a computational approach and can identify drug candidates that show no activity in traditional screens.